Nomura Holdings Inc Exelixis, Inc. Call Options Transaction History

Nomura Holdings Inc

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$21.96 - $27.6 $439,200 - $552,000	-20,000 Reduced 21.39%	73,500 $1.91 Million
Q2 2024 Aug 14, 2024	SELL	$20.34 - $23.73 $48,816 - $56,952	-2,400 Reduced 2.5%	93,500 $2.1 Million
Q1 2024 May 15, 2024	BUY	$20.17 - $23.93 $1.93 Million - $2.29 Million	95,900 New	95,900 $2.28 Million
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $3.34 Million - $4.44 Million	-191,800 Closed	0 $0
Q1 2022 May 18, 2022	BUY	$17.03 - $22.67 $3.27 Million - $4.35 Million	191,800 New	191,800 $4.39 Million
Q1 2020 May 14, 2020	SELL	$14.46 - $21.8 $578,400 - $872,000	-40,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$15.15 - $18.89 $606,000 - $755,600	40,000 New	40,000 $709,000

502

243M

2.54M

2.29M

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $10.7B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.